Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
JPMorgan Chase says profits jumped sharply ias the bank cashed in billions of dollars of its holdings in Visa Inc., also helped by higher interest rates.
Archegos's Bill Hwang turned $10 billion into $160 billion into nothing. Plus: Intuit's layoffs, Elon's travails, Boeing's bad week, Jerome Powell, and mor
Language learning apps surged in 2024, with Babbel offering interactive lessons, vocabulary practice, and grammar exercises for effective language acquisition.
The Mind-Money Connection explores how managing finances can boost happiness and uncover the real impact personal finances have on mental health and well-being.